1.Primary hypertrophic osteoarthropathy accompanied by Crohn's disease: a case report.
Yonsei Medical Journal 1997;38(5):319-322
Primary hypertrophic osteoarthropathy is a rare hereditary disease without evidence of underlying diseases. We report a very unusual case of primary HOA accompanied by Crohn's disease with the primary HOA mimicking secondary HOA, which is a rare manifestation of Crohn's disease. We also review the literature to find the correlation, if any, between the two.
Adult
;
Case Report
;
Crohn Disease/radiography
;
Crohn Disease/pathology
;
Crohn Disease/complications*
;
Human
;
Male
;
Osteoarthropathy, Primary Hypertrophic/radiography
;
Osteoarthropathy, Primary Hypertrophic/complications*
2.A Case of Familial Crohn's Disease Observed in a Parent and His Offspring.
Hyun Seok CHO ; Tae Jun BYUN ; Sang Bong AHN ; Tae Yeob KIM ; Chang Soo EUN ; Yong Cheol JEON ; Yong Seok KIM ; Dong Soo HAN
The Korean Journal of Gastroenterology 2008;52(4):247-250
Crohn's disease (CD), one of the major forms of idiopathic inflammatory bowel disease (IBD), is thought to be related to genetic susceptibility coupled with environmental factors. A positive family history is the strongest risk factor for the development of CD. The 10-fold increase in the familial risk of CD strongly suggests that these disorders have a genetic background. The prevalence of IBD in Asian populations is lower than in Western populations, which may be due to genetic influences, environmental factors, or a combination of both. In a Korean study, only 0.25% of parents had IBD in CD probands and all of them had ulcerative colitis. The term of familial CD was used only for those with one or more first-degree relatives with confirmed CD. There are few case reports about familial Crohn's disease in Korea. We report a case of familial CD that the father, the first degree relative was diagnosed as small bowel CD after confirming his son as having CD.
Child
;
Colonoscopy
;
Crohn Disease/*diagnosis/etiology/radiography
;
Family
;
Genetic Predisposition to Disease
;
Humans
;
Male
;
Middle Aged
;
Pedigree
3.Crohn's Disease of the Small Bowel.
The Korean Journal of Gastroenterology 2005;45(2):75-77
No abstract available
Adult
;
Crohn Disease/*diagnosis/radiography
;
Endoscopy, Gastrointestinal
;
Female
;
Humans
;
Intestine, Small/pathology/radiography
;
Tomography, X-Ray Computed
4.Risk of surgery in patients with stricturing type of Crohn's disease at the initial diagnosis: a single center experience
Yuji MAEHATA ; Yutaka NAGATA ; Tomohiko MORIYAMA ; Yuichi MATSUNO ; Atsushi HIRANO ; Junji UMENO ; Takehiro TORISU ; Tatsuya MANABE ; Takanari KITAZONO ; Motohiro ESAKI
Intestinal Research 2019;17(3):357-364
BACKGROUND/AIMS: It remains uncertain which patients with stricturing-type Crohn's disease (CD) require early small bowel surgery after the initial diagnosis. We aimed to clarify clinical characteristics associated with the intervention in such condition of CD. METHODS: We retrospectively evaluated the clinical course of 53 patients with CD and small bowel strictures who were initially treated with medications after the initial diagnosis. We investigated possible associations between small bowel surgery and the following: clinical factors and radiologic findings at initial diagnosis and the types of medications administered during follow-up. RESULTS: Twenty-eight patients (53%) required small bowel resection during a median follow-up period of 5.0 years (range, 0.5–14.3 years). The cumulative incidence rates of small bowel surgery at 2, 5, and 10 years were 26.4%, 41.0%, and 63.2%, respectively. Univariate analysis indicated that obstructive symptoms (P=0.036), long-segment stricture (P<0.0001), and prestenotic dilation (P<0.0001) on radiography were associated with small bowel surgery, and immunomodulatory (P=0.037) and biological therapy (P=0.008) were significant factors during follow-up. Multivariate analysis revealed that long-segment stricture (hazard ratio [HR], 4.25; 95% confidence interval [CI], 1.78–10.53; P=0.001) and prestenotic dilation (HR, 3.41; 95% CI, 1.24–9.62; P=0.018) on radiography showed a positive correlation with small bowel surgery, and biological therapy (HR, 0.40; 95% CI, 0.15–0.99; P=0.048) showed a negative correlation. CONCLUSIONS: CD patients with long-segment stricture and prestenotic dilation on radiography seem to be at a higher risk of needing small bowel surgery. For such patients, early surgical intervention might be appropriate, even at initial diagnosis.
Biological Therapy
;
Constriction, Pathologic
;
Crohn Disease
;
Diagnosis
;
Follow-Up Studies
;
Humans
;
Incidence
;
Intestine, Small
;
Multivariate Analysis
;
Radiography
;
Retrospective Studies
6.Mesalazine-induced Eosinophilic Pneumonia in a Patient with Crohn's Disease.
Jeung Eun PARK ; Young HWANGBO ; Rin CHANG ; Young Woon CHANG ; Jae Young JANG ; Byung Ho KIM ; Seok Ho DONG ; Hyo Jong KIM
The Korean Journal of Gastroenterology 2009;53(2):116-120
Mesalazine (5-aminosalicylic acid) and sulfasalazine are widely used in the treatment of inflammatory bowel disease. The pulmonary toxicity related to sulfasalazine was well-recognized complication and it was caused by sulfapyridine moiety in sulfasalazine. However, the lung injury related to mesalazine has rarely been reported. A thirty five-year-old man with Crohn's disease who was treated with mesalazine complained fever and dry cough. The finding of bilateral wandering pulmonary infiltration, peripheral eosinophilia and increased eosinophils in bronchoalvolar lavage were consistent with eosinophilic pneumonia. His symptoms and laboratory findings were markedly improved after the discontinuation of mesalazine. The mesalazine-induced eosinophilic pneumonia was diagnosed according to his clinical course. This report shows that the eosinophilic pneumonia should be considered in patients who develope pulmonary involvement with inflammatory bowel disease receiving mesalazine therapy.
Adult
;
Anti-Inflammatory Agents, Non-Steroidal/*adverse effects/therapeutic use
;
Crohn Disease/*drug therapy
;
Humans
;
Lymphocyte Activation
;
Male
;
Mesalamine/*adverse effects/therapeutic use
;
Pulmonary Eosinophilia/chemically induced/*diagnosis/radiography
;
Tomography, X-Ray Computed
7.Metastatic Recurrence of Small Bowel Cancer in Crohn's Disease.
Ji Min CHOI ; Changhyun LEE ; Jong Pil IM
The Korean Journal of Gastroenterology 2014;63(4):258-261
No abstract available.
Adenocarcinoma, Mucinous/diagnosis
;
Colonoscopy
;
Crohn Disease/complications/*pathology
;
Humans
;
Intestinal Neoplasms/*diagnosis/pathology/radiography
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
8.A Case of Plummer-Vinson Syndrome Associated with Crohn's Disease.
Joon Mo PARK ; Kyeong Ok KIM ; Chan Seo PARK ; Byung Ik JANG
The Korean Journal of Gastroenterology 2014;63(4):244-247
Plummer-Vinson syndrome manifests as cervical dysphagia, iron deficiency anemia, an upper esophageal web, and atrophic glossitis. The cause of the esophageal web is thought to be iron deficiency anemia; however, the cause of Plummer-Vinson syndrome has not been established. Crohn's disease is usually accompanied by malnutrition and iron deficiency anemia; however, no case of concomitant Crohn's disease and Plummer-Vinson syndrome with aggravated malnutrition and anemia has been previously reported. Here, we report on a rare case of Plummer-Vinson syndrome in a Crohn's disease patient, which caused malnutrition and constipation.
Adult
;
Cobblestone Lissencephaly/diagnosis
;
Colon, Sigmoid/surgery
;
Crohn Disease/complications/*diagnosis
;
Esophageal Sphincter, Upper/radiography
;
Humans
;
Male
;
Plummer-Vinson Syndrome/*diagnosis/etiology
;
Sigmoidoscopy
;
Sphincterotomy, Endoscopic
;
Tomography, X-Ray Computed
9.Pulmonary Sarcoidosis That Developed During the Treatment of a Patient With Crohn Disease by Using Infliximab.
Tae Kyun KIM ; Sun Hyung KANG ; Hee Seok MOON ; Jae Kyu SUNG ; Hyun Yong JEONG ; Hyuk Soo EUN
Annals of Coloproctology 2017;33(2):74-77
For inflammatory bowel disease (IBD), antitumor necrosis factor treatment offers a new direction for both patients and medical doctors. This treatment has dramatically improved the quality of life for patients with ulcerative colitis and Crohn disease (CD). However, with increasing usage and longer follow-up periods, a wider range of possible adverse effects may be encountered. We report an unusual case of pulmonary sarcoidosis developed during the treatment of a patient with CD by using infliximab. A 30-year-old male who had been treated for CD with infliximab for 18 months was admitted due to abnormal opacities on chest radiography. Chest computed tomography displayed clustered small nodules in both lobes and enlarged multiple lymph nodes. The patient was diagnosed with sarcoidosis from the results of a biopsy of the subcarinal lymph node. Lung lesions were improved five months after infliximab was stopped.
Adult
;
Biopsy
;
Colitis, Ulcerative
;
Crohn Disease*
;
Follow-Up Studies
;
Humans
;
Inflammatory Bowel Diseases
;
Infliximab*
;
Lung
;
Lymph Nodes
;
Male
;
Necrosis
;
Quality of Life
;
Radiography
;
Sarcoidosis
;
Sarcoidosis, Pulmonary*
;
Thorax
;
Tumor Necrosis Factor-alpha
10.Analysis of Risk Factors for Low Bone Mineral Density in Patients with Inflammatory Bowel Disease.
Jae Jung PARK ; Sung Ae JUNG ; Young Wook NOH ; Min Jung KANG ; Ji Min JUNG ; Seong Eun KIM ; Hye Kyung JUNG ; Ki Nam SHIM ; Tae Hun KIM ; Kwon YOO ; Il Hwan MOON ; Young Sun HONG
The Korean Journal of Gastroenterology 2010;55(4):237-244
BACKGROUND/AIMS: Several clinical risk factors for low bone mineral density (BMD) in the patients with inflammatory bowel disease (IBD) have been suggested. However, its prevalence and pathophysiology in Korean population have not been fully studied. The aim of this study was to investigate the prevalence and risk factors for low BMD in Korean IBD patient. METHODS: BMD of the lumbar spine and femur was evaluated using dual-energy X-ray absorptiometry in 30 patients with IBD. Biochemical parameters of bone metabolism, such as serum calcium, phosphorus, osteocalcin, and deoxypyridinoline were measured. The associations between low BMD and clinical parameters such as disease duration, disease activity, drug history, body mass index (BMI), and others were evaluated retrospectively using medical records. RESULTS: Low BMD at the lumbar spine or femur was observed in 63.3% of the patients, and there was no significant difference between the patients with Crohn's disease and ulcerative colitis. Clinical and biochemical parameters were irrelevant to BMD. In the patients without glucocorticoid treatment prior to BMD measurement, already 50.0% of patients had low BMD. CONCLUSIONS: Low BMD is a common feature in Korean IBD patients, even those who do not use glucocorticoid. The multiple factors may be involved in the pathogenesis of low BMD. Therefore, BMD should be examined in all IBD patients, irrespective of glucocorticoid treatment.
Absorptiometry, Photon
;
Adolescent
;
Adult
;
Amino Acids/blood
;
Body Mass Index
;
*Bone Density
;
Calcium/blood
;
Colitis, Ulcerative/diagnosis/radiography
;
Crohn Disease/diagnosis/radiography
;
Female
;
Glucocorticoids/therapeutic use
;
Humans
;
Inflammatory Bowel Diseases/diagnosis/drug therapy/*radiography
;
Male
;
Middle Aged
;
Osteocalcin/blood
;
Phosphorus/blood
;
Prevalence
;
Retrospective Studies
;
Risk Factors